Conceptio › Archive › bioRxiv / medRxiv
bioRxiv / medRxivopen access

A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Escalation Study for the Evaluation of the Safety, Tolerability, and Pharmacokinetics of Recombinant Human Plasma Gelsolin (rhu-pGSN) Following Intravenous Administration to Healthy Volunteers

Liu, Y. et al. · 2026
bioRxiv / medRxiv · Papers · License: Open Access · 2026
Open Source ↗
pharmacology and therapeutics
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 134338
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.